Armetheon is committed to improving the lives of patients with cardiovascular disease by developing potential drug therapies that fulfill unmet needs. We are working to advance alternative treatments that can deliver superior effectiveness to existing medical therapies or offer new therapies for patients who do not have clinically efficacious options.
We understand that the ultimate goal of medicine is to restore people to greater health and help you get back to the life that you deserve. Our medication candidates currently closest to market include an anti-coagulant, also called a blood thinner, and an anti-arrhythmic drug, which counteracts an irregular heartbeat.
Through innovation and research, we’re developing potential drugs that could assist patients with a variety of conditions, including:
- Anti-coagulation for those who don’t tolerate existing therapies
- Need for anti-coagulation after heart valve surgery
- Need for anti-coagulation in patients with kidney problems
- Management of cardiac arrhythmias
We encourage you to learn more about our work in these areas.